Laroche Daniel, Scheive Melanie
Department of Ophthalmology, New York Eye and Ear Infirmary, Icahn School of Medicine of Mount Sinai, New York, NY, USA.
Advanced Eyecare of New York, New York, NY, USA.
Clin Ophthalmol. 2022 Mar 15;16:815-821. doi: 10.2147/OPTH.S354338. eCollection 2022.
Glaucoma continues to be a leading cause of blindness worldwide for the same reasons as in the past several decades, including the lack of early detection, improper treatment, and non-adherence to therapy. Medical therapy continues to be the first-line therapy even as surgical techniques are improving in their safety and efficacy. To turn the tide in preventing blindness from glaucoma, attention must be focused on targeted patient education, screening, effective treatment, and addressing health disparities. To achieve this, early safer cataract surgery and microinvasive glaucoma surgery must be considered as a first-line therapy in addition to medical therapy to best lower both intraocular pressure and the medication burden.
青光眼仍然是全球失明的主要原因,原因与过去几十年相同,包括缺乏早期检测、治疗不当以及不坚持治疗。尽管手术技术在安全性和有效性方面不断提高,但药物治疗仍然是一线治疗方法。为了扭转青光眼致盲的趋势,必须将注意力集中在有针对性的患者教育、筛查、有效治疗以及解决健康差距上。为了实现这一目标,除药物治疗外,早期更安全的白内障手术和微创青光眼手术必须被视为一线治疗方法,以最大程度降低眼压和药物负担。